Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Osteopore Ltd. ( (AU:OSX) ) has shared an update.
Osteopore Limited has announced the opening of a Clinical Centre of Excellence (CCoE) for medial wedge opening high tibial osteotomy (MOWHTO) in collaboration with Total Orthopaedic Care & Surgery. This initiative, led by renowned orthopaedic surgeon Dr. Hamid Razak, aims to enhance the understanding and adoption of MOWHTO techniques among clinicians, providing training and educational sessions to improve patient outcomes. The centre’s establishment follows recent approvals and strategic partnerships, reinforcing Osteopore’s commitment to innovative knee preservation techniques that delay the need for total knee arthroplasty.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean company specializing in regenerative medicine. It is a global leader in 3D-printed biomimetic and bioresorbable implants, focusing on advancing orthopaedic care and improving patient outcomes, particularly in knee preservation.
YTD Price Performance: -45.00%
Average Trading Volume: 259,705
Technical Sentiment Signal: Buy
Current Market Cap: A$2.66M
See more data about OSX stock on TipRanks’ Stock Analysis page.